Clearstead Advisors’s Bausch Health BHC Stock Holding History

Clearstead Advisors’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.4K	Buy	+2,106	New	+$11.3K	﹤0.01%	1965
2024 Q2	–	Sell	-1,000	Closed	-$7.13K	–	2033
2024 Q1	$7.13K	Hold	1,000	–	–	﹤0.01%	1122
2023 Q4	$8.02K	Hold	1,000	–	–	﹤0.01%	1099
2023 Q3	$8.22K	Hold	1,000	–	–	﹤0.01%	1020
2023 Q2	$8K	Hold	1,000	–	–	﹤0.01%	1007
2023 Q1	$8.1K	Hold	1,000	–	–	﹤0.01%	977
2022 Q4	$6.28K	Hold	1,000	–	–	﹤0.01%	960
2022 Q3	$7K	Buy	+1,000	New	+$6.95K	﹤0.01%	927

Other funds holding BHC

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Advisors's BHC Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Bausch Health (BHC) in Q2 2026: 2,106 shares worth $10.4K. The stake represents ﹤0.01% of the portfolio and ranks #1965 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in BHC as recently as Q1 2024.

Clearstead Advisors first reported a position in BHC in Q3 2022 and has held it in 8 quarters since. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

Clearstead Advisors held 2,106 shares of Bausch Health worth $10.4K as of Q2 2026.
Bausch Health was a new Clearstead Advisors position in Q2 2026.
Bausch Health made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1965 holding.
Clearstead Advisors first reported a position in Bausch Health in Q3 2022 and has held it in 8 quarters since.
222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.